PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDatang Intl H Regulatory News (DAT)

Share Price Information for Datang Intl H (DAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.19956
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 16.19956
DAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Connected Transactions Announcement

31 Jan 2011 07:00

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

DATANG INTERNATIONAL POWER GENERATION CO., LTD. (a sino-foreign joint stock limited company incorporated in the People's Republic of China) (Stock Code: 991) CONNECTED TRANSACTIONS ANNOUNCEMENT ON FINANCIAL ASSISTANCE AND ANNOUNCEMENT PURSUANT TO RULE 13.17 OF THE LISTING RULES THE GUARANTEE

The Board announces that Datang Overseas Investment, a wholly-owned subsidiary of CDC, shall enter into a Guarantee with the Bank to pledge 358,680,000 H shares of the Company to the Bank to secure the Loan Facility not exceeding HK$690 million to be provided by the Bank to Hong Kong Company, a wholly-owned subsidiary of the Company.

THE COUNTER GUARANTEE

In consideration of the provision of the Guarantee by Datang Overseas Investment, the Board announces that the Company provided the Counter Guarantee in favour of Datang Overseas Investment on 28 January 2011, pursuant to which the Company agreed to provide a counter guarantee in favour of Datang Overseas Investment against all amounts incurred by Hong Kong Company under the Guarantee.

LISTING RULES IMPLICATIONS As at the date of this announcement, CDC and its subsidiaries hold

approximately 36.07% of the shares in the Company and Datang Overseas Investment is a wholly-owned subsidiary of CDC. Accordingly, Datang Overseas Investment is a connected person of the Company under Chapter 14A of the Listing Rules and the Guarantee and Counter Guarantee constitute connected transactions of the Company. As each of the applicable percentage ratios (as defined under Rule 14.07 of the Listing Rules) in respect of the Guarantee and Counter Guarantee is higher than 0.1% and less than 5%, the Guarantee and Counter Guarantee are only subject to the reporting and announcement

requirements but are exempt from the approval by the independent shareholders of the Company under the requirements of Chapter 14A of the Listing Rules.

Since CDC is the controlling shareholder of the Company, the pledge of the 358,680,000 H shares of the Company by Datang Overseas Investment to the Bank under the Guarantee also triggers disclosure obligation of the Company under Rule 13.17 of the Listing Rules and therefore this announcement is also made by the Company pursuant to Rule 13.17 of the Listing Rules.

THE GUARANTEEParties:(a) The Bank; and

(b) Datang Overseas Investment

Material Terms of the Guarantee:

Under the Guarantee, Datang Overseas Investment will agree to pledge 358,680,000 H shares of the Company to the Bank to secure the Loan Facility to be provided by the Bank to Hong Kong Company. The liability of Datang Overseas Investment in respect of the Guarantee shall include the Loan Facility of not exceeding HK$690 million, any interests accrued thereon, any commissions, fees and charges payable by Hong Kong Company to the Bank and any legal or other costs and expenses incurred by the Bank for the recovery of the Loan Facility from Hong Kong Company.

The Company shall issue a further announcement on the Guarantee in accordance with the requirements of Chapter 14A of the Listing Rules in the event that the terms of the Guarantee (when it is being signed) are materially different from the terms already disclosed in this announcement.

THE COUNTER GUARANTEEDate:28 January 2011Parties:(a) The Company; and

(b) Datang Overseas Investment

Material Terms of the Counter Guarantee:

In consideration of the provision of the Guarantee by Datang Overseas Investment, the Company agreed to provide a counter guarantee in favour of Datang Overseas Investment against all amounts incurred by Hong Kong Company under the Guarantee. The term of the Counter Guarantee commences from the effective date of the Guarantee to the expiry date of the Guarantee and the two-years period thereafter. The Counter Guarantee will be provided on a joint-liability basis.

The Counter Guarantee is conditional upon (i) the Guarantee becoming effective; and (ii) the approval of the relevant matters relating to the Counter Guarantee by the shareholders of the Company in the EGM as required under the Listing Rules of the Shanghai Stock Exchange (Note).

Note:

According to the requirement of the Listing Rules of the Shanghai Stock Exchange, as the asset-liability ratio of Hong Kong Company is over 70%, the relevant matters relating to the Counter Guarantee is required to be submitted to the EGM for shareholders' approval. CDC and its associates shall abstain from voting in the EGM for approving this resolution.

REASONS AND BENEFITS OF ENTERING INTO THE GUARANTEE AND COUNTER GUARANTEE

Through the Guarantee and Counter Guarantee, Hong Kong Company will be granted the Loan Facility to ensure its normal production and operations. The Directors (including independent Directors) are of the view that the Guarantee and Counter Guarantee are conducted on normal commercial terms during the Company's ordinary course of business. These transactions are fair, reasonable and in the interests of the Company and its shareholders as a whole.

LISTING RULES IMPLICATIONS

As at the date of this announcement, CDC and its subsidiaries hold approximately 36.07% of the shares in the Company and Datang Overseas Investment is a wholly-owned subsidiary of CDC. Accordingly, Datang Overseas Investment is a connected person of the Company under Chapter 14A of the Listing Rules and the Guarantee and Counter Guarantee constitute connected transactions of the Company. As each of the applicable percentage ratios (as defined under Rule 14.07 of the Listing Rules) in respect of the Guarantee and Counter Guarantee is higher than 0.1% and less than 5%, the Guarantee and Counter Guarantee are only subject to the reporting and announcement requirements but are exempt from the approval by the independent shareholders of the Company under the requirements of Chapter 14A of the Listing Rules.

Since CDC is the controlling shareholder of the Company, the pledge of the 358,680,000 H shares of the Company by Datang Overseas Investment to the Bank under the Guarantee also triggers disclosure obligation of the Company under Rule 13.17 of the Listing Rules and therefore this announcement is also made by the Company pursuant to Rule 13.17 of the Listing Rules.

BOARD'S APPROVAL

The Counter Guarantee was considered and approved by the Board on 28 January 2011. Mr. Liu Shunda, Mr. Hu Shengmu and Mr. Fang Qinghai, Directors who have material interests in the transaction (by virtue of being the principal management staff of CDC) have abstained from voting at the Board meeting for approval of the Counter Guarantee.

INFORMATION ON RELEVANT PARTIES

1. Information relating to the Company

The Company is principally engaged in the construction and operation of power plants, the sale of electricity and thermal power, the repair and maintenance of power equipment and power related technical services, with its main service areas being in the PRC.

As at the date of this announcement, the Company's aggregate external guarantees amounted to approximately RMB5,692.12 million (unaudited), accounting for 17.40% of the latest audited net assets of approximately RMB32,716.94 million, which were all guarantees for the Company's subsidiaries, jointly-controlled entities and associated companies. There were no overdue external guarantees.

2. Information relating to Hong Kong Company

Hong Kong Company, a wholly-owned subsidiary of the Company, was set up in Hong Kong in 2004 with a registered capital of US$2.9 million. It is principally engaged in the development of power projects, coal trading and trading in the four major pipelines for power plants.

3. Information relating to Datang Overseas Investment

Datang Overseas Investment was set up by CDC in Hong Kong in November 2006 and is its wholly-owned subsidiary with a registered capital of US$5.0 million. It is principally engaged in the development, investment, construction, operation and management of electrical energy in China and overseas; the organisation of production and sale of electricity (including thermal power); the self-operation or agency representation in the imports and exports of various types of merchandises and technologies (except for the merchandises and technologies which were restricted from operation by the Company or prohibited from importing and exporting by the State); the contracting for overseas projects and exports of equipment and materials required therefor; the development, transportation and trading of mineral resources including coal; as well as asset management.

DEFINITIONS

In this announcement, unless the context otherwise requires, the following expressions have the following meanings:

"Bank" Bank of China (Hong Kong) Limited "Board" the board of Directors "CDC" China Datang Corporation, a State-owned enterprise established under the laws of the PRC and a substantial shareholder of the Company pursuant to the Listing Rules which together with its subsidiaries own approximately 36.07% of the issued share capital of the Company as at the date of this announcement "Company" Datang International Power Generation Co., Ltd., a sino-foreign joint stock limited company incorporated in the PRC on 13 December 1994, whose H Shares are listed on the Stock Exchange and the London Stock Exchange and whose A Shares are listed on the Shanghai Stock Exchange "Counter Guarantee" the counter guarantee dated 28 January 2011 executed by the Company in favour of Datang Overseas Investment in respect of the Guarantee "Datang Overseas China Datang Overseas Investment Co., Limited, a Investment" wholly-owned subsidiary of CDC "Director(s) " the director(s) of the Company "EGM" the extraordinary general meeting of the Company to be held on 22 March 2011 at the function room of 5/F, InterContinental Hotel, No.11 Financial Street, Xicheng District, Beijing, the PRC to consider and approve, among others, the Counter Guarantee "Guarantee" the deed of guarantee to be entered into between the Bank and Datang Overseas Investment to provide security for the Loan Facility provided by the Bank to Hong Kong Company "Hong Kong Company" Datang International (Hong Kong) Limited, a wholly-owned subsidiary of the Company "Listing Rules" The Rules Governing the Listing of Securities on the Stock Exchange "Loan Facility" a general banking facility of not exceeding the sum of HK$690 million agreed to be made available to Hong Kong Company by the Bank "PRC" the People's Republic of China "RMB" Renminbi, the lawful currency of the PRC "Stock Exchange" The Stock Exchange of Hong Kong Limited By Order of the Board Zhou Gang Secretary to the Board

Beijing, the PRC, 28 January 2011

As at the date of this announcement, the Directors of the Company are:Liu Shunda, Hu Shengmu, Cao Jingshan, Fang Qinghai, Zhou Gang, Liu Haixia, Guan Tiangang, Su Tiegang, Ye Yonghui, Li Gengsheng, Li Yanmeng*, Zhao Zunlian*, Li Hengyuan*, Zhao Jie*, Jiang Guohua*

* Independent non-executive directors

vendor
Date   Source Headline
7th May 20247:00 amPRNMonthly Return
26th Apr 20242:56 pmPRNCONNECTED TRANSACTION ANNOUNCEMENT
26th Apr 20242:54 pmPRNFirst Quarterly Report of 2024
26th Apr 20242:50 pmPRNCHANGE OF JOINT COMPANY SECRETARY ANNOUNCEMENT
26th Apr 20242:44 pmPRN2023 Annual Report
22nd Apr 202412:18 pmPRNOverseas Regulatory Announcement
16th Apr 20241:56 pmPRNNotice of Board of Directors Meeting
8th Apr 202411:54 amPRNNotification to Non-registered Shareholders and Form
8th Apr 202411:21 amPRNNotification Letter to Registered Shareholders and Form
2nd Apr 202411:21 amPRNMonthly Return
22nd Mar 20247:14 pmPRN2023 Social Responsibility Report
22nd Mar 20247:13 pmPRNResolutions of the Board of Directors
22nd Mar 20247:12 pmPRNFinal Dividend for the Year Ended 31 December 2023
22nd Mar 20247:09 pmPRNAnnouncement of 2023 Annual Results
22nd Mar 20246:59 pmPRNResolution Passed at the 2024 First Extraordinary General Meeting
22nd Mar 20246:56 pmPRNAnnouncement on Provisions for Asset
12th Mar 202411:23 amPRNNotice of board of directors meeting
5th Mar 202412:33 pmPRNMonthly Return
4th Mar 20241:16 pmPRNProxy Form For Use At The 2024 First Extraordinary General Meeting
4th Mar 20241:15 pmPRNNotice of Extraordinary General Meeting
1st Mar 20241:14 pmPRNAnnouncement Major Transactions 2024 Financial Agreement
1st Mar 20241:00 pmPRNAnnouncement On Resolutions Of The Board Of Directors
2nd Feb 20249:43 amPRNMonthly Return
30th Jan 202411:01 amPRNOverseas Regulatory Announcement
30th Jan 202411:00 amPRNOverseas Regulatory Announcement
30th Jan 202410:57 amPRNInside Information Announcement
2nd Jan 20249:31 amPRNMonthly Return
28th Dec 202312:36 pmPRNConnected Transaction Announcement
28th Dec 202312:23 pmPRNOverseas Regulatory Announcement
27th Dec 202310:01 amPRNConnected Transaction Announcement
22nd Dec 20237:00 amPRNOverseas Regulatory Announcement
22nd Dec 20237:00 amPRNTerms of Reference of the Audit Committee
22nd Dec 20237:00 amPRNAnnouncement Regarding Resignation of General Manager
22nd Dec 20237:00 amPRNOverseas Regulatory Announcement
22nd Dec 20237:00 amPRNTerms of Reference of the Nomination Committee
22nd Dec 20237:00 amPRNTerms of Reference of the Remuneration and Appraisal Committee
22nd Dec 20237:00 amPRNList of Directors and Their Roles and Functions
22nd Dec 20235:46 amPRNResolutions Passed at the 2023 Fourth Extraordinary General Meeting
4th Dec 20239:36 amPRNMonthly Return
1st Dec 20232:02 pmPRNProxy form
1st Dec 20232:01 pmPRNOverseas Regulatory Announcement
1st Dec 20231:57 pmPRNNotice of 2023 fourth extraordinary general meeting
24th Nov 202311:17 amPRNConnected Transaction Capital Increase Agreement
23rd Nov 20231:54 pmPRNResolution of the Supervisory Committee
23rd Nov 20231:52 pmPRNAnnouncement on Resolutions of the Board of Directors
2nd Nov 20239:21 amPRNAnnouncement of Monthly Returns
26th Oct 20233:12 pmPRNAnnouncement on Resolutions of the Board of Directors
26th Oct 20233:08 pmPRNConnected Transaction Capital Increase Agreement
26th Oct 20233:01 pmPRNThird Quarterly Report of 2023
12th Oct 20231:58 pmPRNNotice of Board of Directors Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.